Latest News

Eyenuk gets greenlight to market AI screening system in European Union
Eyenuk gets greenlight to market AI screening system in European Union

January 31st 2023

According to the company, the approval allows Eyenuk’s EyeArt AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss.

Glaucoma surgical device lowers IOP level
Glaucoma surgical device lowers IOP level

January 30th 2023

Individualized patient care increases adherence to glaucoma therapy
Individualized patient care increases adherence to glaucoma therapy

January 29th 2023

Study: Atropine drops after glaucoma surgery may impair vision, prolong rehabilitation
Study: Atropine drops after glaucoma surgery may impair vision, prolong rehabilitation

January 26th 2023

Glaucoma 360: Innovation taking center stage
Glaucoma 360: Innovation taking center stage

January 24th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.